XML 29 R9.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities attributable to continuing operations:      
Net earnings $ 551,313 $ 651,472 $ 359,919
Add back: loss from discontinued operations, net of tax 0 0 2,211
Net earnings from continuing operations 551,313 651,472 362,130
Adjustments to reconcile net earnings from continuing operations to net cash provided by operating activities attributable to continuing operations:      
Stock-based compensation expense 267,381 232,099 203,880
Depreciation 87,499 61,807 43,594
Impairments and amortization of intangibles 74,175 47,731 366,257
Deferred income taxes (14,952) 26,612 (29,953)
Other adjustments, net 2,019 9,932 6,998
Changes in assets and liabilities      
Accounts receivable (29,788) (107,412) (6,669)
Other assets 25,337 25,055 59,584
Accounts payable and other liabilities (9,395) (5,961) (472,610)
Income taxes payable and receivable 22,213 (3,337) (1,054)
Deferred revenue (43,083) (41,207) (6,469)
Net cash provided by operating activities attributable to continuing operations 932,719 896,791 525,688
Cash flows from investing activities attributable to continuing operations:      
Capital expenditures (50,578) (67,412) (49,125)
Other, net (7,960) (9,169) (22,577)
Net cash used in investing activities attributable to continuing operations (58,538) (76,581) (71,702)
Cash flows from financing activities attributable to continuing operations:      
Payments to settle exchangeable notes 0 0 (176,310)
Proceeds from the settlement of exchangeable note hedges 0 0 75,864
Payments to settle warrants related to exchangeable notes 0 0 (7,482)
Proceeds from issuance of common stock pursuant to stock-based awards 13,584 19,916 20,485
Withholding taxes paid on behalf of employees on net settled stock-based awards (11,441) (5,933) (109,256)
Purchase of treasury stock (752,674) (546,198) (482,049)
Purchase of noncontrolling interests (1,291) (1,872) (10,554)
Other, net (6,482) 19 129
Net cash used in financing activities attributable to continuing operations (758,304) (534,068) (689,173)
Total cash provided by (used in) continuing operations 115,877 286,142 (235,187)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (12,324) 3,782 (7,809)
Net increase (decrease) in cash, cash equivalents, and restricted cash 103,553 289,924 (242,996)
Cash, cash equivalents, and restricted cash at beginning of period 862,440 572,516 815,512
Cash, cash equivalents, and restricted cash at end of period $ 965,993 $ 862,440 $ 572,516